CAMBRIDGE, Mass. — The fate of the most promising Alzheimer’s drug in decades was sealed with a text message.

It was sent to Al Sandrock, one of the most celebrated drug developers of his generation. He and his employer, Biogen (BIIB), the pioneering biotech firm, had spent a dozen years and hundreds of millions of dollars developing the drug. It was the talk of neuroscience; it had been featured on the cover of Fortune — a sign of hope for the entire field.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I am so sorry to hear this disappointing news. So very sorry for the families with people suffering along with their loved ones who have dementia / Alzheimer’s. After studying about statin drugs, how they work on the HMG-CoA Reductase Enzyme in the mevalonate pathway of the liver, I can not understand why science continues to encourage the use of statins. The brain needs cholesterol! The neuron’s need cholesterol for the myelin sheath that protects the axon and enables the neurons to send their electrical signals to one another without interruption. The synapse between neurons relies on cholesterol to function. YET, statin drugs diminish or eliminate the liver’s ability to make cholesterol! If someone you know is having any type of dementia, check their meds list to see if they are taking a statin. Dr. Mark Hyman, Director of Functional Medicine at the Cleveland Clinic believes no woman over 69 should ever be on a statin. People need to understand the importance of cholesterol – without it we could not live! We need to understand the new cholesterol testing that every person should insist on getting when the doctor wants to check their cholesterol. That test is the Particle Test.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy